Cargando…

Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study

The association between frailty, disability in activities of daily living (ADL), polypharmacy, and quality of life (QoL) in middle-aged patients with cardiovascular disease (CVD) is little investigated. This study sought (a) to explore this association comparatively in elderly and middle-aged hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiriscau, Elisabeta Ioana, Buzdugan, Elena-Cristina, Hui, Ligia-Ancuta, Bodolea, Constantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871852/
https://www.ncbi.nlm.nih.gov/pubmed/35206472
http://dx.doi.org/10.3390/ijerph19042286
_version_ 1784657094809485312
author Hiriscau, Elisabeta Ioana
Buzdugan, Elena-Cristina
Hui, Ligia-Ancuta
Bodolea, Constantin
author_facet Hiriscau, Elisabeta Ioana
Buzdugan, Elena-Cristina
Hui, Ligia-Ancuta
Bodolea, Constantin
author_sort Hiriscau, Elisabeta Ioana
collection PubMed
description The association between frailty, disability in activities of daily living (ADL), polypharmacy, and quality of life (QoL) in middle-aged patients with cardiovascular disease (CVD) is little investigated. This study sought (a) to explore this association comparatively in elderly and middle-aged hospitalized patients with CVD and (b) to determine which domains of ADL and QoL might improve the frailty prediction. A one-year follow-up study including 90 elderly (≥65 years old) and 89 middle-aged patients (40–65 years old) was conducted. At baseline, frailty assessment was performed based on the Fried criteria; Barthel Index (BI) and Duke Activity Status Index (DASI) were used for ADL, and European Quality of Life-5 dimensions (EQ-5D) for QoL. At follow-up, data were collected via telephone. At baseline, 79 patients (51 elderly and 28 middle-aged) were frail. The CVD frail patients showed functional dependency and a poor QoL compared to the non-frail (p < 0.001) and within each subgroup at follow-up. Mobility was found to predict frailty in both elderly (OR = 2.34) (C.I. (1.03–5.29)) and middle-aged patients (OR = 2.58) (C.I. (1.15–5.78)). The ADL assessment and self-reported QoL may help to identify an aggravation or an advanced frailty condition in hospitalized elderly and middle-aged CVD patients.
format Online
Article
Text
id pubmed-8871852
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88718522022-02-25 Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study Hiriscau, Elisabeta Ioana Buzdugan, Elena-Cristina Hui, Ligia-Ancuta Bodolea, Constantin Int J Environ Res Public Health Article The association between frailty, disability in activities of daily living (ADL), polypharmacy, and quality of life (QoL) in middle-aged patients with cardiovascular disease (CVD) is little investigated. This study sought (a) to explore this association comparatively in elderly and middle-aged hospitalized patients with CVD and (b) to determine which domains of ADL and QoL might improve the frailty prediction. A one-year follow-up study including 90 elderly (≥65 years old) and 89 middle-aged patients (40–65 years old) was conducted. At baseline, frailty assessment was performed based on the Fried criteria; Barthel Index (BI) and Duke Activity Status Index (DASI) were used for ADL, and European Quality of Life-5 dimensions (EQ-5D) for QoL. At follow-up, data were collected via telephone. At baseline, 79 patients (51 elderly and 28 middle-aged) were frail. The CVD frail patients showed functional dependency and a poor QoL compared to the non-frail (p < 0.001) and within each subgroup at follow-up. Mobility was found to predict frailty in both elderly (OR = 2.34) (C.I. (1.03–5.29)) and middle-aged patients (OR = 2.58) (C.I. (1.15–5.78)). The ADL assessment and self-reported QoL may help to identify an aggravation or an advanced frailty condition in hospitalized elderly and middle-aged CVD patients. MDPI 2022-02-17 /pmc/articles/PMC8871852/ /pubmed/35206472 http://dx.doi.org/10.3390/ijerph19042286 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hiriscau, Elisabeta Ioana
Buzdugan, Elena-Cristina
Hui, Ligia-Ancuta
Bodolea, Constantin
Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study
title Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study
title_full Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study
title_fullStr Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study
title_full_unstemmed Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study
title_short Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study
title_sort exploring the relationship between frailty, functional status, polypharmacy, and quality of life in elderly and middle-aged patients with cardiovascular diseases: a one-year follow-up study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871852/
https://www.ncbi.nlm.nih.gov/pubmed/35206472
http://dx.doi.org/10.3390/ijerph19042286
work_keys_str_mv AT hiriscauelisabetaioana exploringtherelationshipbetweenfrailtyfunctionalstatuspolypharmacyandqualityoflifeinelderlyandmiddleagedpatientswithcardiovasculardiseasesaoneyearfollowupstudy
AT buzduganelenacristina exploringtherelationshipbetweenfrailtyfunctionalstatuspolypharmacyandqualityoflifeinelderlyandmiddleagedpatientswithcardiovasculardiseasesaoneyearfollowupstudy
AT huiligiaancuta exploringtherelationshipbetweenfrailtyfunctionalstatuspolypharmacyandqualityoflifeinelderlyandmiddleagedpatientswithcardiovasculardiseasesaoneyearfollowupstudy
AT bodoleaconstantin exploringtherelationshipbetweenfrailtyfunctionalstatuspolypharmacyandqualityoflifeinelderlyandmiddleagedpatientswithcardiovasculardiseasesaoneyearfollowupstudy